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We report the first genetic characterization of wildtype
measles viruses from Uganda. Thirty-six virus isolates from
outbreaks in 6 districts were analyzed from 2000 to 2002.
Analyses of sequences of the nucleoprotein (N) and
hemagglutinin (H) genes showed that the Ugandan isolates
were all closely related, and phylogenetic analysis indicat-
ed that these viruses were members of a unique group
within clade D. Sequences of the Ugandan viruses were
not closely related to any of the World Health Organization
reference sequences representing the 22 currently recog-
nized genotypes. The minimum nucleotide divergence
between the Ugandan viruses and the most closely related
reference strain, genotype D2, was 3.1% for the N gene
and 2.6% for the H gene. Therefore, Ugandan viruses
should be considered a new, proposed genotype (d10).
This new sequence information will expand the utility of
molecular epidemiologic techniques for describing measles
transmission patterns in eastern Africa.
M
easles virus is a negative-sense, single-stranded
RNA virus in the genus Morbillivirus within the
family Paramyxoviridae. Infection with this virus is typi-
fied by high fever, maculopapular rash, conjunctivitis,
cough, and coryza (1). Although a vaccine-preventable
disease, it still accounts for ≈770,000 deaths annually
worldwide, half of which occur in Africa (2).
This virus is monotypic, but genetic variation in the
hemagglutinin (H) and nucleoprotein (N) genes can be
analyzed by molecular epidemiologic techniques to study
transmission patterns. This molecular information, in con-
junction with standard case reporting and investigation, is
useful in assessing the effectiveness of vaccination pro-
grams (3–5). Genetic characterization of wildtype measles
virus is a key component of laboratory surveillance activi-
ties in all phases of measles control. To facilitate genetic
characterization of measles viruses, a uniform nomencla-
ture and analysis protocol was recommended by the World
Health Organization (WHO) (6). WHO currently recog-
nizes 22 genotypes of measles virus and has established
guidelines for the designation of new genotypes (5–8).
In Uganda, measles is still endemic despite the avail-
ability of a measles vaccine for almost 2 decades. This
failure to completely control measles is mainly the result
of inadequate coverage of measles immunization, which
is a single dose of vaccine given at 9 months of age. The
reported measles vaccination coverage rate in 2002 was
only 74%. Given a seroconversion rate of ≈85% for
measles vaccine given at 9 months of age, ≈37% of
Ugandan children are expected to remain susceptible to
measles. The measles vaccination coverage increased to
83% in 2003 and 2004. The number of measles cases
reported to the Ugandan National Health Management
Information System ranged from 57,347 in 1997 to 49,871
in 2002. Of the cases reported in 2002, 31% occurred in
persons >5 years of age. The Ministry of Health devel-
oped a 5-year plan (2002–2006) aimed at reducing the ill-
ness and death caused by measles virus. The strategies
include increasing routine immunization coverage, con-
ducting vaccination campaigns for children 6 months to
15 years of age, providing vitamin A, and initiating a case-
based measles surveillance system. In October 2003,
Uganda conducted a catch-up campaign for children 6
months to 15 years of age that reached ≈13.5 million chil-
dren with measles vaccine, with a national coverage of
105%. This campaign resulted in a decrease in reported
measles cases to 3,522 from January to August 2004,
compared with 28,072 in 2003 and 33,633 in 2002 in the
same period, with no deaths among confirmed measles
cases as of August 2004. Case-based measles surveillance
was established in 2003, and by August 2004, >80% of
districts were investigating measles cases according to the
guidelines.
Some information is available on circulating measles
virus genotypes in western, central, and southern Africa,
but little is known about circulating strains in eastern
Africa, including Uganda. The WHO Regional Measles
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undertook the present study to isolate and characterize cir-
culating measles strains in Uganda. 
Materials and Methods
Specimen Collection and Virus Isolation
Specimens for virus isolation were collected from out-
breaks in different districts of Uganda, sentinel sites, and
Mulago hospital, the national teaching and referral hospi-
tal, in Kampala from 2000 to 2002. Staff members from
the UVRI were part of the outbreak investigation team and
responsible for collecting specimens. Urine and nasopha-
ryngeal aspirate specimens were obtained <7 days of onset
of a rash according to WHO procedures for laboratory
diagnosis of measles viral infection (9) and transported to
UVRI for processing by using standard procedures. 
The specimens were added onto B95a cells (10) that
had been seeded into 25-cm2 tissue culture flasks and
observed daily for characteristic cytopathic effect (CPE).
Infected cells were harvested when >75% of the culture
showed CPE, and viral stocks were prepared and stored at
–70°C in 0.5-mL aliquots. Specimens contaminated with
bacteria or fungi were filtered through a 0.45-µm filter,
and tissue culture additions were repeated. Isolates were
shipped to the Centers for Disease Control and Prevention
(CDC) in Atlanta, Georgia, for molecular analysis.
Polymerase Chain Reaction and Sequencing
At CDC, the isolates were passaged once in B95a cells.
RNAwas extracted from infected cells by using the guani-
dinium acid-phenol technique (11), and reverse transcrip-
tase-polymerase chain reaction (RT-PCR) was used to
amplify either the 550 nucleotides (nt) coding for the
COOH terminus of N or the full-length open reading frame
for H (12). PCR products were purified by using the PCR
Preps DNA Purification System (Promega, Madison, WI,
USA) and analyzed by agarose gel electrophoresis fol-
lowed by staining with ethidium bromide. Templates were
sequenced by using a cycle sequencing reaction with fluo-
rescent dye terminators (Perkin-Elmer, Applied
Biosystems Division, Foster City, CA, USA), and the reac-
tion products were analyzed by using an ABI 3100
(Perkin-Elmer) automatic sequencer. Sequence data from
multiple reactions were analyzed with version 10.1 of the
Genetics Computer Group Package (Accelrys, San Diego,
CA, USA). Phylogenetic analyses, including bootstrap
analysis, were performed by using PAUP version 4.01
(Sinauer Associates, Sunderland, MA, USA). The
sequence of the 450 nt coding for the 150 amino acids at
the COOH terminus of the N gene was obtained for all the
isolates, and the entire coding region of the H gene was
sequenced for 2 representative isolates.
Results
Thirty-six measles virus isolates obtained from measles
outbreaks (n = 8) and Mulago Hospital (n = 28) from 2000
to 2002 were selected for genetic analysis. Isolates were
obtained from 6 districts within Uganda (Table 1 and
Figure 1), although most were obtained from patients in
Kampala. Viruses were isolated from either urine or respi-
ratory samples collected within 7 days of rash onset.
Overall, virus isolations were successful in 14% of the
specimens. 
Sequence data from this report are available from
GenBank under accession nos. AY923185–AY923212 and
AY923213–AY92321. All sequences were derived from
viral isolates that were passaged once in B95a cells. The
region of the N gene that is routinely sequenced for geno-
typing is not affected by tissue culture passage (5,6).
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Ugandan isolates were all closely related and composed of
2 clusters (Figure 2 and Table 2). Most of the Ugandan
sequences were in a single cluster in which the sequences
differed by <6 nt (1.3%). Within this large cluster, 2 groups
were composed of 14 and 9 viruses each that had identical
N-gene sequences. Nucleotide divergence within the
smaller cluster was 0.6%, and overall, Ugandan viruses
differed from each other by 0–11 nt (0%–2.4%) in the N
gene. Viruses from Mpigi, Kampala, and Jinja were found
in both clusters, and viruses from Lira, Wakiso, and Rakai
were part of the larger cluster. The sequence of the entire
coding region of the H gene was obtained for 2 of the
Ugandan viruses (MVi/Kampala.UGA/51.00-1 and MVi/
Kampala.UGA/3.01). The Ugandan H-gene sequences
differed by 21 nt (1.1%) and 6 predicted amino acids
(Figure 3). 
Phylogenetic analyses based on both N and H gene
sequences showed that the Ugandan viruses were members
of clade D. However, the sequences of the Ugandan virus-
es were not closely related to the sequences of any WHO
reference sequences that represented the 22 currently rec-
ognized genotypes. The Ugandan sequences were closest
to the sequence of the genotype D2 reference strain. The
minimum nucleotide divergence between the Ugandan
viruses and the D2 reference strain was 3.1% for the N
gene and 2.6% for the H gene (Table 2). 
Bootstrap analysis of Ugandan H-gene sequences and
the WHO reference sequences showed 100% confidence in
the group containing Ugandan viruses. When N-gene
sequences were compared with WHO reference sequences
and contemporary genotype D2 (13) and D4 (14,15)
sequences, bootstrap support for the Ugandan branch was
100% (data not shown). Therefore, based on the current
WHO recommendations for designating a new genotype
(7,8,16), the Ugandan viruses should be considered as a
new genotype of measles. The proposed genotype that
includes the Ugandan viruses is genotype d10.
Mvi/Kampala.UGA/51.00-1 (GenBank accession nos.
N:AY923185, H:AY923213) was chosen as the reference
strain for d10 because it represents most isolates and grows
to high titers in cell culture.
Discussion
This is the first report of the genetic characterization of
wildtype measles from Uganda and the second that
describes characterization of viruses from eastern Africa.
Although this study was successful, it highlights some of
the difficulties in performing virologic surveillance in
developing countries. The relatively low rate of virus iso-
lation in this study was surprising considering that all the
specimens were collected within 7 days of rash onset.
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Figure 1. Map of Uganda showing districts where measles virus
isolates were obtained from 2000 to 2002.
Figure 2. Phylogenetic analysis of sequences of nucleoprotein
genes (450 nucleotides) of wildtype measles viruses isolated in
Uganda during 2000–2002. The unrooted tree shows sequences
from Ugandan viruses compared with World Health Organization
reference strains for each genotype. Genotype designation is in
bold. However, many specimens were not collected properly,
and many arrived at the laboratory in poor condition
because of inadequate transportation. Better training and
adequate specimen-collection equipment and supplies
could prevent some of these problems. In addition, many
of the specimens were contaminated, and the filtration step
for removing the contaminants reduced the viral titer.
Specimens that do not require reverse cold chain, such as
blood spots dried onto filter paper, will improve the effi-
ciency of virologic surveillance in countries such as
Uganda.
Our results show that the percentage sequence diver-
gence between the N and H gene sequence of the Ugandan
virus isolates and the sequences of the reference strains
exceeds the recommended threshold for designation of a
new measles genotype, which is 2.5% and 2.0% minimum
nucleotide divergence for the COOH region of the N and
H genes, respectively (7,8,16). Phylogenetic analyses
group these viruses in clade D. The results also showed
that the Ugandan viruses had sequences that were unique
among all previously characterized wildtype measles
viruses and constitute a new genotype, which we propose
to be genotype d10. All viruses isolated over the 2-year
period from 6 districts in Uganda belonged to this single,
proposed new genotype. Therefore, d10 should be consid-
ered the endemic genotype in Uganda. The degree of
genetic relatedness observed for the Ugandan viruses is
surprising since these viruses were isolated during a peri-
od when measles was widespread in the country. Previous
genetic analyses of wildtype measles viruses from coun-
tries with endemic measles have shown more genetic het-
erogeneity within a genotype, which suggested the
presence of multiple chains of transmission (12,17,18).
The Ugandan viruses have a unique genetic signature
that clearly distinguishes them from other African viruses.
During the time when d10 viruses were isolated in
Uganda, genotype D4 viruses were circulating in nearby
Kenya (15) and genotypes D4 and D8 were detected in
Ethiopia (14). Genotype B3, the most prevalent genotype
in western Africa, has also been detected in Sudan and
Democratic Republic of Congo, which are north and west,
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Figure 3. Phylogenetic analysis of sequences of hemagglutinin
genes of wildtype measles viruses isolated in Uganda during
2000–2002. The unrooted tree shows sequences from the
Ugandan viruses compared with World Health Organization refer-
ence strains for each genotype. Genotype designation is in bold.respectively, of Uganda (18–23). D2 and D4 are the most
frequently detected genotypes in southern Africa (24),
while genotype C2 viruses were detected in northern
Africa in Morocco (25). Baseline virologic surveillance
has not been conducted in Tanzania, Rwanda, or Burundi,
the countries that border Uganda to the south. Therefore,
the exact geographic distribution of genotype d10 viruses
is unknown.
The purpose of virologic surveillance is to establish the
transmission pathways of measles virus. Both Uganda and
Kenya have initiated accelerated measles control activities
and successfully completed a baseline survey of viral
genotypes. Molecular epidemiologic techniques will now
be very useful in monitoring the transmission pathways in
eastern Africa, contribute to the development of effective
measles control strategies, and document the success of the
measles vaccination program.
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